Plus Therapeutics Ownership | Who Owns Plus Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Plus Therapeutics Ownership Summary


Plus Therapeutics is owned by 9.56% institutional investors, 1.15% insiders, and 89.28% retail investors. Vanguard group is the largest institutional shareholder, holding 2.12% of PSTV shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.85% of its assets in Plus Therapeutics shares.

PSTV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPlus Therapeutics9.56%1.15%89.28%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group2.28M2.12%$1.17M
Blackrock funding, inc. /de1.78M1.65%$910.03K
Geode capital management1.40M1.31%$719.03K
Jane street group1.02M0.95%$524.55K
Ubs group875.85K0.82%$448.43K
State street341.89K0.71%$233.75K
Northern trust265.49K0.55%$181.51K
Scientech research146.65K0.30%$100.27K
Mercer global advisors inc /adv28.47K0.06%$19.47K
Kestra advisory services25.80K0.05%$17.64K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Scientech research146.65K0.03%$100.27K
Dagco25.88K0.00%$13.26K
Two sigma securities11.08K0.00%$7.57K
Ashton thomas private wealth24.91K0.00%$12.76K
Tower research capital llc (trc)3.52K0.00%$2.41K
J.w. cole advisors10.00K0.00%$5.12K
Ubs group875.85K0.00%$448.43K
Kestra advisory services25.80K0.00%$17.64K
Jane street group1.02M0.00%$524.55K
Atlantic union bankshares---

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.78M-1.31M
Jane street group1.02M0.00%1.02M
Vanguard group2.28M-832.59K
Geode capital management1.40M-589.54K
State street341.89K-341.89K

Top Sellers

HolderShares% AssetsChange
Altium capital management lp---918.91K
Hrt financial lp---102.06K
Virtu financial---40.03K
Goldman sachs group---26.75K
Ground swell capital---11.45K

New Positions

HolderShares% AssetsChangeValue
State street341.89K-341.89K$233.75K
Northern trust265.49K-265.49K$181.51K
Scientech research146.65K0.03%146.65K$100.27K
Citigroup48.46K-48.46K$24.82K
Mercer global advisors inc /adv28.47K-28.47K$19.47K

Sold Out

HolderChange
Group one trading-1.00
Jones financial companies lllp-26.00
Tradewinds capital management-200.00
Atlantic union bankshares-500.00
Ground swell capital-11.45K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202519-17.39%10,271,35596.96%98.23%13-35.00%1-50.00%
Sep 30, 20252335.29%5,214,8311279.19%10159.96%2081.82%2-33.33%
Jun 30, 2025176.25%378,108-2.84%25.96%1110.00%350.00%
Mar 31, 20251660.00%389,160-42.62%64.99%10150.00%2-
Dec 31, 202410-678,1730.98%1115.74%4---100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr1.51M0.85%-
Fidelity Extended Market Index733.80K0.41%203.96K
Blackrock Extended Mkt Fund CF462.94K0.26%462.94K
Extended Equity Market Fund K397.07K0.22%258.00
Fidelity Total Market Index249.15K0.14%83.16K
Fidelity Series Total Market Index178.30K0.10%43.98K
NT Ext Equity Mkt Idx Fd - L165.03K0.09%64.39K
Spartan Extended Market Index Pool F133.66K0.07%1.02K
NT Ext Equity Mkt Idx Fd - NL123.10K0.07%-41.68K
Abante Quant Value FI114.25K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 04, 2025Sims Andrew John Hugh MacIntyre Chief Financial OfficerBuy$10.20K
Aug 22, 2025Lenk Robert P-Buy$53.78K
Sep 13, 2024Hawkins Richard J-Buy$6.00K
Sep 12, 2024Hawkins Richard J-Buy$8.51K
Sep 11, 2024Petersen Greg-Buy$16.88K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q41-
2025 Q31-
2025 Q2--
2025 Q1--

PSTV Ownership FAQ


Who Owns Plus Therapeutics?

Plus Therapeutics shareholders are primarily institutional investors at 9.56%, followed by 1.15% insiders and 89.29% retail investors. The average institutional ownership in Plus Therapeutics's industry, Biotech Stocks , is 381.47%, which Plus Therapeutics falls below.

Who owns the most shares of Plus Therapeutics?

Plus Therapeutics’s largest shareholders are Vanguard group (2.28M shares, 2.12%), Blackrock funding, inc. /de (1.78M shares, 1.65%), and Geode capital management (1.4M shares, 1.31%). Together, they hold 5.08% of Plus Therapeutics’s total shares outstanding.

Does Blackrock own Plus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Plus Therapeutics.

Who is Plus Therapeutics’s biggest shareholder by percentage of total assets invested?

Scientech research is Plus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 146.65K Plus Therapeutics shares, valued at 100.27K$.

Who is the top mutual fund holder of Plus Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Plus Therapeutics shares, with 0.85% of its total shares outstanding invested in 1.51M Plus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools